Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-06-15

Fate Therapeutics (FATE)

Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$2,248,568
Bahram Valamehr total, FY2025
CEO pay percentile vs peers
CEO-to-median pay ratio
97.03%
Say-on-pay support, latest vote
Companies that benchmark against FATE
7 companies name FATE as a compensation peer

Each company listed discloses FATE in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named FATE in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Bahram Valamehr$600,000$0$0$1,283,868$360,000$0$4,700$2,248,568
President, Chief Executive Officer and Director
Cindy Tahl520,000092,400286,896208,00004,7001,111,996
Chief Legal & Compliance Officer and Corporate Secretary
Kamal Adawi99,0000115,500456,00039,60004,700714,800
Chief Financial Officer and Treasurer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY20242025
Bahram Valamehr$2,248,568$3,584,600−1,336,032
Cindy Tahl1,111,9963,421,100−2,309,104
Kamal Adawi714,800

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
William H. RastetterDirector2026-05-05A25,000$2$42,250CommonForm 4 ↗
Robert S. EpsteinDirector2026-05-05A25,00000Derivative, Class A CommonForm 4 ↗
Robert S. EpsteinDirector2026-05-05A25,000242,250CommonForm 4 ↗
William H. RastetterDirector2026-05-05A25,00000Derivative, Class A CommonForm 4 ↗
Cindy TahlSee Remarks2026-05-06D122,22000Derivative, Class A CommonForm 4 ↗
Cindy TahlSee Remarks2026-05-06A122,2201161,330CommonForm 4 ↗
Cindy TahlSee Remarks2026-05-06D44,44400Derivative, Class A CommonForm 4 ↗
Cindy TahlSee Remarks2026-05-06A44,444146,666CommonForm 4 ↗
Bahram ValamehrDirector2026-05-20D28,946254,482Common, open-market saleForm 4 ↗
Cindy TahlSee Remarks2026-05-20D25,590248,084Common, open-market saleForm 4 ↗
Yuan XuDirector2026-06-12A87,90000Derivative, Class A CommonForm 4 ↗
Redmile Group, LLCDirector2026-06-12A87,90000Derivative, Class A CommonForm 4 ↗
Karin JoossDirector2026-06-12A87,90000Derivative, Class A CommonForm 4 ↗
Matthew C. AbernethyDirector2026-06-12A87,90000Derivative, Class A CommonForm 4 ↗
Michael LeeDirector2026-06-12A87,90000Derivative, Class A CommonForm 4 ↗
Robert S. EpsteinDirector2026-06-12A87,90000Derivative, Class A CommonForm 4 ↗
Laura J. HamillDirector2026-06-12A175,80000Derivative, Class A CommonForm 4 ↗
Shefali AgarwalDirector2026-06-12A87,90000Derivative, Class A CommonForm 4 ↗
William H. RastetterDirector2026-06-12A87,90000Derivative, Class A CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Cindy TahlOption$286,896
Cindy TahlRSU92,400
Kamal AdawiOption456,000
Kamal AdawiRSU115,500
Bahram ValamehrOption1,283,868
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Cindy Tahl$92,400$0$286,8960.0%
Kamal Adawi115,5000456,0000.0%
Bahram Valamehr001,283,8680.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Bahram ValamehrOption902,7791.25
Kamal AdawiOption375,0001.54
Cindy TahlOption153,4786.76
Bahram ValamehrOption1,10639.87
Bahram ValamehrOption12,5016.77
Bahram ValamehrOption162,5016.76
Cindy TahlOption1,10639.87
Cindy TahlOption11,8066.77
Cindy TahlOption190,9751.32
05

Incentive-plan design — the Compensation Discussion & Analysis

Each year, the Compensation Committee reviews the Company's compensation policies and programs to ensure that these policies and programs enhance shareholder value, align pay and performance, and attract and retain top executive talent.

CEO STI target (% of salary)60%
CEO LTI target (% of salary)
Independent consultantAon's Human Capital Solutions practice (Radford)
Clawback policyTrue
Anti-hedgingTrue
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-06-1259,168,6891,808,66973,30497.03%Passed
20242024-06-0765,401,63525,615,148433,96471.86%Passed
20232023-06-0673,720,4422,955,50361,93896.15%Passed
20222022-06-0975,409,6099,055,375281,39589.28%Passed
20212021-06-0275,621,3211,509,26734,08398.04%Passed
20202020-05-0156,002,8843,656,40755,16693.87%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-06-1297.03%a
20242024-06-0771.86%b
20232023-06-0696.15%c

a. Approved under the standard stated in the filing — “If 2 Table of Contents you abstain from voting on this matter, your shares will not be counted as "votes cast" with respect to such matter, and the abstention will have no effect on the proposal.”.

b. Approved under the standard stated in the filing — “If you abstain from voting on this matter, your shares will not be counted as "votes cast" with respect to such matter, and the abstention will have no effect on the proposal.”.

c. Approved under the standard stated in the filing — “If you abstain from voting on this matter, your shares will not be counted as "votes cast" with respect to such matter, and the abstention will have no effect on the proposal.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)
CEO total compensation
Median employee compensation
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Matthew C. AbernethyIndependent · Audit (Chair) · Newly elected$35,440$0$116,172$0$151,612
William H. RastetterIndependent · Board Chair · Audit84,896058,0860142,982
Robert S. EpsteinIndependent · Audit · Compensation · Nominating/Governance (Chair)65,625058,0860123,711
Karin JoossIndependent · Compensation (Chair) · Science & Technology60,875058,0860118,961
Shefali AgarwalIndependent · Nominating/Governance · Science & Technology (Chair)57,000058,0860115,086
Yuan XuIndependent · Compensation · Science & Technology53,438058,0860111,524
Michael LeeIndependent · Science & Technology46,000058,0860104,086
Neelufar MozaffarianIndependent · Departed during FY38,250058,086096,336
John D. MendleinIndependent · Departed during FY34,500058,086092,586
Timothy P. CoughlinIndependent · Not standing for re-election · Departed during FY26,2250026,225
Bahram ValamehrEmployee director00000
Laura J. HamillIndependent · Newly elected00000
09

Board fee structure and ownership guideline

Annual cash retainer$40,000
Annual equity retainer
Per board meeting fee
Committee chair fees (audit / comp / nom-gov)15,000 / 12,000 / 10,000
Stock ownership guideline
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$502,249
Equity awards (grant-date value)$0
All other compensation$0
Total cost of the board$502,249

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Fate Therapeutics2025Bahram Valamehr$600,000$0$1,283,868$360,000$2,248,568

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Bahram ValamehrDEF 14A2026-04-240001193125-26-177094Section “2025 Summary Compensation Table”. As printed: 2,248,568. Filing ↗machine: r2 · c31 · span 391551–391560
2Section 01, Cindy TahlDEF 14A2026-04-240001193125-26-177094Section “2025 Summary Compensation Table”. As printed: 1,111,996. Filing ↗machine: r6 · c31 · span 400096–400105
3Section 01, Kamal AdawiDEF 14A2026-04-240001193125-26-177094Section “2025 Summary Compensation Table”. As printed: 714,800. Filing ↗machine: t109 · r4 · c31 · span 396362–396369
4Section 03, Cindy Tahl OptionDEF 14A2026-04-240001193125-26-177094Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t109 · r6 · c19 · span 399423–399430
5Section 03, Cindy Tahl RSUDEF 14A2026-04-240001193125-26-177094Section “FOR THE APPROVAL, ONNON-BINDING ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY&” · grants of plan-based awards table. Filing ↗machine: t99 · r6 · c11 · span 346240–346246
6Section 03, Kamal Adawi OptionDEF 14A2026-04-240001193125-26-177094Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t109 · r4 · c19 · span 395690–395697
7Section 03, Kamal Adawi RSUDEF 14A2026-04-240001193125-26-177094Section “FOR THE APPROVAL, ONNON-BINDING ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY&” · grants of plan-based awards table. Filing ↗machine: t99 · r5 · c11 · span 344712–344719
8Section 03, Bahram Valamehr OptionDEF 14A2026-04-240001193125-26-177094Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t109 · r2 · c19 · span 390876–390885
9Section 07, pay ratio10-K2026-02-260001193125-26-073699Section “CEO Pay Ratio”. As printed: —. Filing ↗
10Section 08, Matthew C. AbernethyDEF 14A2026-04-240001193125-26-177094Section “Director Compensation”. As printed: 151,612. Filing ↗
11Section 08, William H. RastetterDEF 14A2026-04-240001193125-26-177094Section “Director Compensation”. As printed: 142,982. Filing ↗
12Section 08, Robert S. EpsteinDEF 14A2026-04-240001193125-26-177094Section “Director Compensation”. As printed: 123,711. Filing ↗
13Section 08, Karin JoossDEF 14A2026-04-240001193125-26-177094Section “Director Compensation”. As printed: 118,961. Filing ↗
14Section 08, Shefali AgarwalDEF 14A2026-04-240001193125-26-177094Section “Director Compensation”. As printed: 115,086. Filing ↗
15Section 08, Yuan XuDEF 14A2026-04-240001193125-26-177094Section “Director Compensation”. As printed: 111,524. Filing ↗
16Section 08, Michael LeeDEF 14A2026-04-240001193125-26-177094Section “Director Compensation”. As printed: 104,086. Filing ↗
17Section 08, Neelufar MozaffarianDEF 14A2026-04-240001193125-26-177094Section “Director Compensation”. As printed: 96,336. Filing ↗
18Section 08, John D. MendleinDEF 14A2026-04-240001193125-26-177094Section “Director Compensation”. As printed: 92,586. Filing ↗
19Section 08, Timothy P. CoughlinDEF 14A2026-04-240001193125-26-177094Section “Director Compensation”. As printed: 26,225. Filing ↗
20Section 08, Bahram ValamehrDEF 14A2026-04-240001193125-26-177094Section “Director Compensation”. As printed: 0. Filing ↗
21Section 08, Laura J. HamillDEF 14A2026-04-240001193125-26-177094Section “Director Compensation”. As printed: 0. Filing ↗
22Section 02, William H. Rastetter 2026-05-05Form 42026-05-060001193125-26-208891Insider equity transaction reported since the proxy statement. Filing ↗
23Section 02, Robert S. Epstein 2026-05-05Form 42026-05-060001193125-26-208899Insider equity transaction reported since the proxy statement. Filing ↗
24Section 02, Robert S. Epstein 2026-05-05Form 42026-05-060001193125-26-208899Insider equity transaction reported since the proxy statement. Filing ↗
25Section 02, William H. Rastetter 2026-05-05Form 42026-05-060001193125-26-208891Insider equity transaction reported since the proxy statement. Filing ↗
26Section 02, Cindy Tahl 2026-05-06Form 42026-05-070001193125-26-211820Insider equity transaction reported since the proxy statement. Filing ↗
27Section 02, Cindy Tahl 2026-05-06Form 42026-05-070001193125-26-211820Insider equity transaction reported since the proxy statement. Filing ↗
28Section 02, Cindy Tahl 2026-05-06Form 42026-05-070001193125-26-211820Insider equity transaction reported since the proxy statement. Filing ↗
29Section 02, Cindy Tahl 2026-05-06Form 42026-05-070001193125-26-211820Insider equity transaction reported since the proxy statement. Filing ↗
30Section 02, Bahram Valamehr 2026-05-20Form 42026-05-210001193125-26-234380Insider equity transaction reported since the proxy statement. Filing ↗
31Section 02, Cindy Tahl 2026-05-20Form 42026-05-210001193125-26-234390Insider equity transaction reported since the proxy statement. Filing ↗
32Section 02, Yuan Xu 2026-06-12Form 42026-06-150001193125-26-271090Insider equity transaction reported since the proxy statement. Filing ↗
33Section 02, Redmile Group, LLC 2026-06-12Form 42026-06-150001104659-26-074130Insider equity transaction reported since the proxy statement. Filing ↗
34Section 02, Karin Jooss 2026-06-12Form 42026-06-150001193125-26-271088Insider equity transaction reported since the proxy statement. Filing ↗
35Section 02, Matthew C. Abernethy 2026-06-12Form 42026-06-150001193125-26-271074Insider equity transaction reported since the proxy statement. Filing ↗
36Section 02, Michael Lee 2026-06-12Form 42026-06-150001104659-26-074126Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, Robert S. Epstein 2026-06-12Form 42026-06-150001193125-26-271083Insider equity transaction reported since the proxy statement. Filing ↗
38Section 02, Laura J. Hamill 2026-06-12Form 42026-06-150001193125-26-271069Insider equity transaction reported since the proxy statement. Filing ↗
39Section 02, Shefali Agarwal 2026-06-12Form 42026-06-150001193125-26-271079Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, William H. Rastetter 2026-06-12Form 42026-06-150001193125-26-271072Insider equity transaction reported since the proxy statement. Filing ↗
41Section 06, 2026 voteForm 8-K2026-06-150001193125-26-271055Item 5.07 · say-on-pay result. As reported: 97.03% (votes for as printed: 59,168,689). Filing ↗
42Section 06, 2024 voteForm 8-K2024-06-070001193125-24-157554Item 5.07 · say-on-pay result. As reported: 71.86% (votes for as printed: 65,401,635). Filing ↗
43Section 06, 2023 voteForm 8-K2023-06-090000950170-23-027262Item 5.07 · say-on-pay result. As reported: 96.15% (votes for as printed: 73,720,442). Filing ↗
44Section 01 trend, Δ column (computed)ComputedcomputedΔ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
45Section 03b vehicle mix (computed)ComputedcomputedRSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
46Section 09b board cost (computed)ComputedcomputedCash 502,249 + equity 0 + all other 0 = 502,249, summed across the director compensation table rows.machine: formula: Σ = 502,249
47Fate Therapeutics (subject), Section 10b CEO totalDEF 14A2026-04-240001193125-26-177094CEO total compensation as printed in Fate Therapeutics's own proxy. As printed: 2,248,568. Filing ↗machine: r2 · c31 · span 391551–391560